{"transactions":[{"id":743264,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:03.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265904","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000119312526265904/ownership.xml","form_type":"4"}},{"id":1119852,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:51:09.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000095017025083306/ownership.xml","form_type":"4"}},{"id":1490176,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T00:05:55.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":102225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2024 with respect to 102,225 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":102225,"derivative":{"exercise_price":6.79,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":102225},"source":{"system":"sec-edgar","filing":"0000950170-24-069560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000095017024069560/ownership.xml","form_type":"4"}},{"id":1872171,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T22:37:44.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":66055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2023 with respect to 66,055 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":66055,"derivative":{"exercise_price":11.14,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":66055},"source":{"system":"sec-edgar","filing":"0001209191-23-033436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000120919123033436/doc4.xml","form_type":"4"}},{"id":2163207,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-09T00:31:27.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":25000,"price":29.95,"value":748750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2022."}],"balance_after":996952,"source":{"system":"sec-edgar","filing":"0001209191-22-049246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000120919122049246/doc4.xml","form_type":"4"}},{"id":2253664,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:41:18.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":41597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":41597,"derivative":{"exercise_price":17.33,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":41597},"source":{"system":"sec-edgar","filing":"0001209191-22-032685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000120919122032685/doc4.xml","form_type":"4"}},{"id":2701078,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T23:44:37.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 19, 2021 with respect to 16,000 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":16000,"derivative":{"exercise_price":30.09,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-21-035114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000120919121035114/doc4.xml","form_type":"4"}},{"id":3078948,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T23:19:24.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":990099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":278829},"source":{"system":"sec-edgar","filing":"0000899243-20-019846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000089924320019846/doc4.xml","form_type":"4"}},{"id":3078947,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-21T23:19:24.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":281617},"source":{"system":"sec-edgar","filing":"0000899243-20-019846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000089924320019846/doc4.xml","form_type":"4"}},{"id":3078946,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T23:19:24.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":25000,"price":20,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 20, 2020, the reporting person purchased 25,000 shares of Common Stock of the Issuer at a price of $20.00 per share pursuant to an underwritten public offering."}],"balance_after":1021952,"source":{"system":"sec-edgar","filing":"0000899243-20-019846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000089924320019846/doc4.xml","form_type":"4"}},{"id":3078945,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T23:19:24.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":278829,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."}],"balance_after":996952,"source":{"system":"sec-edgar","filing":"0000899243-20-019846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000089924320019846/doc4.xml","form_type":"4"}},{"id":3078944,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T23:19:24.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":281617,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."}],"balance_after":718123,"source":{"system":"sec-edgar","filing":"0000899243-20-019846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000089924320019846/doc4.xml","form_type":"4"}}]}